These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15991152)

  • 1. Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials.
    Liu C; Waters DD
    Prog Cardiovasc Dis; 2005; 47(4):230-9. PubMed ID: 15991152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fulfillment of Koch's postulates and the causes of atherosclerosis.
    O'Connor S
    Am Heart J; 1999 Nov; 138(5 Pt 2):S550-1. PubMed ID: 10539872
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlamydia pneumoniae and atherosclerosis.
    Campbell LA; Kuo CC
    Semin Respir Infect; 2003 Mar; 18(1):48-54. PubMed ID: 12652454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.
    Ieven MM; Hoymans VY
    J Clin Microbiol; 2005 Jan; 43(1):19-24. PubMed ID: 15634945
    [No Abstract]   [Full Text] [Related]  

  • 5. Atherosclerosis: lipid infiltration or Chlamydia pneumoniae infection?
    Shor A
    Circulation; 2002 Oct; 106(18):e135-6; disscussion e135-6. PubMed ID: 12403680
    [No Abstract]   [Full Text] [Related]  

  • 6. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?
    Campbell LA; Kuo CC
    Nat Rev Microbiol; 2004 Jan; 2(1):23-32. PubMed ID: 15035006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumoniae and atherosclerosis.
    Hoymans VY; Bosmans JM; Ieven M; Vrints CJ
    Acta Chir Belg; 2002 Oct; 102(5):317-22. PubMed ID: 12471763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Chlamydia pneumoniae in atherosclerosis.
    Watson C; Alp NJ
    Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients?
    Tsirpanlis G
    Kidney Blood Press Res; 2004; 27(3):134-42. PubMed ID: 15114030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between Chlamydia pneumoniae and atherosclerosis].
    Gayet A; Baril L; Orfila J
    Presse Med; 2001 Dec; 30(36):1792-801. PubMed ID: 11771205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chlamydia pneumoniae as a pathogenetic risk factor in the development of arteriosclerosis and its complications].
    Nagornev VA; Mal'tseva SV; Seliverstova VG; Sokurenko GIu; Voskan'iants AN
    Arkh Patol; 2004; 66(2):52-60. PubMed ID: 15154386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chlamydia pneumoniae, atherosclerosis, and coronary disease].
    Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G
    Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    J Infect Dis; 2000 Jun; 181 Suppl 3():S402-10. PubMed ID: 10839724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't.
    Ngeh J; Anand V; Gupta S
    Clin Microbiol Infect; 2002 Jan; 8(1):2-13. PubMed ID: 11906495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and peripheral blood mononuclear cells infectious burden: correlation to inflammation and atherosclerosis in haemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Ioannidis A; Boufidou F; Moutafis S; Nicolaou C
    Nephrology (Carlton); 2005 Jun; 10(3):256-63. PubMed ID: 15958038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae.
    Gupta S
    Atherosclerosis; 1999 Mar; 143(1):1-6. PubMed ID: 10208475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.
    Campbell LA; Rosenfeld ME
    Front Cell Infect Microbiol; 2014; 4():34. PubMed ID: 24711989
    [No Abstract]   [Full Text] [Related]  

  • 18. Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension.
    Müller J; Møller DS; Kjaer M; Nyvad O; Larsen NA; Pedersen EB
    Scand J Infect Dis; 2003; 35(10):704-12. PubMed ID: 14606608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia pneumoniae infection and atherosclerosis: methodological considerations.
    Kuo CC; Campbell LA; Rosenfeld ME
    Circulation; 2002 Jan; 105(4):E34. PubMed ID: 11815446
    [No Abstract]   [Full Text] [Related]  

  • 20. Seroepidemiological evidence for an association between Chlamydia pneumoniae and atherosclerosis.
    Orfila JJ
    Atherosclerosis; 1998 Oct; 140 Suppl 1():S11-5. PubMed ID: 9859919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.